DNAV has released a new transmission router from Sierra Automated Systems (SAS), which the companies will demonstrate at the ...
Lungpacer Medical announced that it received FDA investigational device exemption (IDE) approval to begin a trial for its ...
The investigational AeroNova® System delivers continual diaphragm neurostimulation in conjunction with mechanical ventilation ...
The STARI trial (NCT06832306), a Phase 2 feasibility study, will explore the potential of transvenous diaphragm neurostimulation-assisted ventilation (DNAV) in mechanically ventilated patients ...
MyChesCo on MSN1d
Lungpacer Medical Secures FDA Approval for AHRF TrialLungpacer Medical has announced that the U.S. Food and Drug Administration (FDA) has approved an Investigational Device ...
The investigational AeroNova® System delivers continual diaphragm neurostimulation in conjunction with mechanical ventilation and is designed to mitigate the negative effects of ventilation that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback